Three Doses of Hepatitis A Vaccine in Patients With Immunomodulating Drugs

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
Hepatitis A vaccine is the most frequently used traveler\'s vaccine, yet data on its ability to induce protective immunity in immunosuppressed travelers are scarce. The investigators assess the hepatitis A virus (HAV) antibody response in patients with rheumatoid arthritis (RA) treated with Tumor Necrosis Factor (TNF) - inhibitors and/or methotrexate (Mtx). In a previous study, 2 doses were not considered effective and there is therefore need for a study with an additional dose
Epistemonikos ID: d5ab6ebc14894f0274d99ce123e15447fbe52e84
First added on: May 10, 2024